Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
van Vollenhoven, Ronald F. [2 ]
Sunkureddi, Prashanth [3 ]
Zhang, Ying [4 ]
Suboticki, Jessica L. [5 ]
Smolen, Josef S. [6 ,7 ]
机构：
[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[2] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] AbbVie Inc, N Chicago, IL USA
[5] AbbVie Inc, Mettawa, IL USA
[6] Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria
[7] Hietzing Hosp, Vienna, Austria
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2456
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Ability of Patients with Early Rheumatoid Arthritis to Taper Low-Dose Glucocorticoids on Methotrexate Monotherapy and in Combination with Adalimumab
    Smolen, Josef S.
    Sunkureddi, Prashanth
    Anderson, Jaclyn K.
    Griffith, Jenny
    Jiang, Dingfeng
    Chen, Kun
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [42] Characteristics of Patients with Early Rheumatoid Arthritis Who Have a Delayed Response to Treatment with Methotrexate in Monotherapy or in Combination with Adalimumab
    Smolen, Josef S.
    Bu, Xianwei
    Wang, Xin
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [43] CHARACTERISTICS OF PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WHO HAVE A DELAYED RESPONSE TO TREATMENT WITH METHOTREXATE IN MONOTHERAPY OR IN COMBINATION WITH ADALIMUMAB
    Smolen, J.
    Bu, X.
    Wang, X.
    Suboticki, J.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 605 - 605
  • [44] Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
    Udachkina, E. V.
    Novikova, D. S.
    Popkova, T. V.
    Panasyuk, E. Yu.
    Avdeeva, A. S.
    Volkov, A. V.
    Kirillova, I. G.
    Markelova, E. I.
    Aleksandrova, E. N.
    Novikov, A. A.
    Nasonov, E. L.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (05) : 510 - 516
  • [45] Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate
    Altawil, Reem
    Saevarsdottir, Saedis
    Wedren, Sara
    Alfredsson, Lars
    Klareskog, Lars
    Lampa, Jon
    ARTHRITIS CARE & RESEARCH, 2016, 68 (08) : 1061 - 1068
  • [46] The Relationship Between Efficacy and Toxicity in Patients with Rheumatoid Arthritis Receiving Methotrexate in Combination with Adalimumab
    Burmester, Gerd
    Kaeley, Gurjit S.
    Kavanaugh, Arthur
    Gabay, Cem
    MacCarter, Daryl
    Nash, Peter
    Takeuchi, Tsutomu
    Cardoso, Anabela
    Liu, Shufang
    Kupper, Hartmut
    Kalabic, Jasmina
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [47] In early rheumatoid arthritis combination therapy with methotrexate and infliximab is more efficacious than methotrexate alone - Comment
    Montecucco, C
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (03) : 291 - 291
  • [48] Inhibition of radiographic disease progression in patients with long-standing rheumatoid arthritis following 3 years of treatment with adalimumab (HUMIRA®) plus methotrexate
    Keystone, EC
    Kavanaugh, AF
    Sharp, JT
    Spencer-Green, GT
    Perez, JL
    Sasso, EH
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 419 - 419
  • [49] Urinary excretion of α-GST and albumin in rheumatoid arthritis patients treated with methotrexate or other DMARDs alone or in combination with NSAIDs
    Svendsen, KB
    Ellingsen, T
    Bech, JN
    Pfeiffer-Jensen, M
    Stengaard-Pedersen, K
    Pedersen, EB
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (01) : 34 - 39
  • [50] The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease
    Matucci-Cerinic, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (01) : 34 - 35
12345